Cover Image

Deletions in metastatic colorectal cancer with chromothripsis

Summary. Aim: In our previously reported study, we found a correlation between DNA massive fragmentation and increased progression free survival (PFS) in metastatic colorectal cancer (mCRC), but not overall survival. The aim of this study is to find overlapping deleted genome regio...

Full description

Saved in:

Bibliographic Details
Date:	2023
Main Authors:	Skuja, E., Butane, D., Nakazawa-Miklasevica, M., Daneberga, Z., Purkalne, G., Miklasevics, E.
Format:	Article
Language:	English
Published:	PH Akademperiodyka 2023
Subjects:	chromothripsis deletion metastatic colorectal cancer progression free survival
Online Access:	https://exp-oncology.com.ua/index.php/Exp/article/view/2019-4-3
Tags:	Add Tag No Tags, Be the first to tag this record!
Journal Title:	Experimental Oncology

Institution

Experimental Oncology

Similar Items

Tumor-associated redox state in metastatic colorectal cancer
by: Burlaka, A.P., et al.
Published: (2023)

Cytochrome P450 content in primary tumors and liver metastases of patients with metastatic colorectal cancer
by: Burlaka, A.P., et al.
Published: (2023)

Molecular mechanisms of oxidation damage and liver cell dysfunction in patients with metastatic colorectal cancer
by: Burlaka, A.P., et al.
Published: (2023)

Drag reducing polymers attenuate adverse effects of ischemia-reperfusion upon resection of liver metastases modeled by MC38 mouse colon adenocarcinomama
by: Burlaka, А.А., et al.
Published: (2023)

Prognostic factors in metastatic gastric carcinoma
by: Ben Kridis, W., et al.
Published: (2023)

DNA oxidation in patients with metastastic colorectal cancer: clinical significance of 8-hydroxy-deoxyguanosine as an independent prognostic factor
by: Burlaka, A.A., et al.
Published: (2023)

Prognostic role of androgen receptor expression in patients with metastatic triple negative breast cancer
by: Lyalkin, S.A., et al.
Published: (2023)

Liver surgery in metastatic colorectal cancer patients
by: O. O. Kolesnik, et al.
Published: (2018)

Incidence and long-term effects of treatment of malignant germ cell neoplasms in Ukraine
by: Fedorenko, Z.P., et al.
Published: (2023)

High expression of GLI1 is associated with better survival in advanced SCLC
by: Kozirovskis, V., et al.
Published: (2023)

Role of ABC-cassette transporters (MDR1, MRP1, BCRP) in the development of primary and acquired multiple drug resistance in patients with early and metastatic breast cancer
by: Kovalev, A.A., et al.
Published: (2013)

Burden of malignant melanoma in Ukraine in 2002–2013: incidence, mortality and survival
by: Korovin, S., et al.
Published: (2023)

Bladder sparing surgery in high-grade bladder cancer
by: Yakovlev, P.G., et al.
Published: (2023)

Integral characteristic of the immune system state predicts breast cancer outcome
by: Stakheyeva, M., et al.
Published: (2023)

Thyroid metastasis of vaginal leiomyosarcoma: a case report and review of the literature
by: Golovko, A., et al.
Published: (2023)

Superoxide- and NO-dependent mechanisms of formation of metastatic microenvironment distant sites of metastasis in patients with colorectal cancer
by: A. P. Burlaka, et al.
Published: (2017)

A network model for structural survivability
by: Додонов, О. Г., et al.
Published: (2021)

Impact of KRAS variant rs61764370 on breast cancer morbidity
by: M. Ustinova, et al.
Published: (2015)

Impact of KRAS variant rs61764370 on breast cancer morbidity
by: Ustinova, M., et al.
Published: (2015)

Positron emission tomography/computed tomography in locally advanced breast cancer
by: Ozkan, E.
Published: (2013)

Peculiarities of abnormal karyotypes formation in therapy-related acute leukemias
by: Andreieva, S.V., et al.
Published: (2023)

Epigenetics in breast cancer
by: Atalay, C.
Published: (2013)

Staging, risk assessment and screening of breast cancer
by: Yalcin, B.
Published: (2013)

Male breast cancer: clinical presentation, diagnosis, treatment
by: Hotko, Y.S.
Published: (2013)

Postmastectomy radiation therapy in locally advanced breast cancer
by: Yavas, G., et al.
Published: (2013)

Specialized care provided to patients with rectal cancer in Kyiv city
by: Kliusov, O.M.
Published: (2023)

A rare coincidence: facioscapulohumeral muscular dystrophy and breast cancer
by: Yazici, O., et al.
Published: (2013)

Tumor microenvironment-derived miRNAs as prognostic markers of breast cancer
by: Lukianova, N.Yu., et al.
Published: (2023)

Receptor status of tumor as prognostic factor in patients with bilateral breast cancer
by: Tsyhyka, D.Y., et al.
Published: (2013)

Overview on locally advanced breast cancer: defining, epidemiology, and overview on neoadjuvant therapy
by: Yalcin, B.
Published: (2013)

Management of non-inflammatory locally advanced breast cancer: focus on surgical approaches
by: Eroğlu, A., et al.
Published: (2013)

Role of postmastectomy radiation therapy after neoadjuvant chemotherapy in locally advanced breast cancer
by: Akyurek, S., et al.
Published: (2013)

NANOG as prognostic factor of prostate cancer course
by: Zadvornyi, T.V., et al.
Published: (2023)

Cytostatic cancer therapy modulates monocyte-macrophage cell functions: how it impacts on treatment outcomes
by: Patysheva, M., et al.
Published: (2023)

TRP genes family expression in colorectal cancer
by: Y. Sozucan, et al.
Published: (2015)

TRP genes family expression in colorectal cancer
by: Sozucan, Y., et al.
Published: (2015)

Disseminated tumor cells and enhanced level of some cytokines in bone marrow and peripheral blood of breast cancer patients as predictive factors of tumor progression
by: Semesiuk, N., et al.
Published: (2013)

Prognostic significance of microRNA-200b and ERCC1 expression in tumor cells of patients with esophageal cancer
by: Kirkilevsky, S.I., et al.
Published: (2023)

Survival rates of familial and sporadic prostate cancer patients
by: J. Plonis, et al.
Published: (2015)

Survival rates of familial and sporadic prostate cancer patients
by: Plonis, J., et al.
Published: (2015)